ARCHIVES

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

This article is from The Cancer Letter archive.

Vol. 36 No. 44 | December 3, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Proposes Three New Grant Programs In Nutrition And Research; DRCCA Board, NCAB Approval Required

November 28, 1980

ASCO Seeks “Nothing Less Than A Smoke-Free World”

June 6, 2003

NIh Clinical Center Urged To Create Governing Board

March 15, 1996

NCI-Approved Clinical Trials

January 27, 2006

Reaction To PSA Guideline Muffled Compared to 2009 Mammography Guideline

October 14, 2011

NCI Support Crucial for Israel cancer Studies; Weizmann Top Recipient

June 17, 1977